As an adjunctive treatment, empagliflozin improves glycaemic control in patients with HNF1A-related maturity-onset diabetes ...

Type 2 diabetes becomes more dangerous to the heart the longer a person has it. Researchers found that after several years, ...

The findings suggest a possible avenue for improving predictions of who may or may not develop diabetes later in life.

A new study found that people with type 2 diabetes who drank diet soda didn't get any healthier when switching to water—in ...

“Integrating these data in large samples allowed us to identify early metabolic pathway changes that precede type 2 diabetes, providing new insights into disease mechanisms,” said Jun Li, MD, ...

BMJ study links high intake of processed foods with preservatives like potassium sorbate and sodium nitrite to increased cancer and Type 2 Diabetes risk.

Monthly injections, once-daily pills, and even lifelong gene therapies could soon become options for people looking to lose ...

New research has shown that the introduction childhood screening for type 1 diabetes is ‘effective’ and would help reduce ...

Cardiovascular risk factor control in Mexican adults with diabetes is suboptimal, with low rates of glycemic, blood pressure, ...

Scientists are developing a "sponge" that can soak up pain signals in the body before they reach the brain, potentially ...

A large meta-analysis, published in Diabetology & Metabolic Syndrome, suggested that semaglutide improved several liver-related and metabolic outcomes in people with or at risk of developing MASH, ...

In a reminder of the money still on the table for enticing obesity assets, Corxel Pharmaceuticals has raised $287 million in ...